MISC

2005年7月

Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin

JAPANESE JOURNAL OF CLINICAL ONCOLOGY
  • A Uchida
  • ,
  • M Tabata
  • ,
  • K Kiura
  • ,
  • Y Tanimoto
  • ,
  • A Kanehiro
  • ,
  • M Aoe
  • ,
  • N Ohohara
  • ,
  • H Ueoka
  • ,
  • M Tanimoto

35
7
開始ページ
417
終了ページ
419
記述言語
英語
掲載種別
DOI
10.1093/jjco/hyi106
出版者・発行元
OXFORD UNIV PRESS

We describe a case of 63-year-old woman with pulmonary artery sarcoma successfully treated with chemotherapy. She developed acute shortness of breath, and left chest and shoulder pain. Although a diagnosis of acute pulmonary embolism was made at a local hospital and she received anticoagulation and thrombolysis therapy, no improvement was achieved. Thereafter, she underwent a pulmonary thromboectomy in our hospital, and the histological diagnosis was intimal sarcoma of the pulmonary artery. Since post-operative computed tomography (CT) scans of the chest showed obvious persistence of an intraluminal hypoattenuated area in the left main pulmonary artery, the patient was treated with four cycles of a doublet chemotherapy consisting of ifosfamide (2.5 g/m(2)/day) on days 1-5 and epirubicin (45 mg/m(2)/day) on days 2 and 3. CT scans of the chest after four cycles showed marked regression of the intraluminal hypoattenuated area in the left main pulmonary artery. This is the first case of pulmonary artery sarcoma responding to chemotherapy. Surgical resection is currently the most hopeful treatment for pulmonary artery sarcoma. However, intensive chemotherapy is worth trying in unresectable patients.

リンク情報
DOI
https://doi.org/10.1093/jjco/hyi106
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000231348600010&DestApp=WOS_CPL
ID情報
  • DOI : 10.1093/jjco/hyi106
  • ISSN : 0368-2811
  • Web of Science ID : WOS:000231348600010

エクスポート
BibTeX RIS